世界の医薬品有効成分市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV02082)
◆英語タイトル:Global Active Pharma Ingredient Market Insights and Forecast to 2026
◆商品コード:QYR20NV02082
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:183
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは医薬品有効成分の世界市場について調査・分析した資料です。種類別(革新的医薬品有効成分、ジェネリック医薬品有効成分)の市場規模、用途別(腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別医薬品有効成分の競争状況、市場シェア
・世界の医薬品有効成分市場:種類別市場規模 2015年-2020年(革新的医薬品有効成分、ジェネリック医薬品有効成分)
・世界の医薬品有効成分市場:種類別市場規模予測 2021年-2026年(革新的医薬品有効成分、ジェネリック医薬品有効成分)
・世界の医薬品有効成分市場:用途別市場規模 2015年-2020年(腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他)
・世界の医薬品有効成分市場:用途別市場規模予測 2021年-2026年(腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他)
・北米の医薬品有効成分市場分析:米国、カナダ
・ヨーロッパの医薬品有効成分市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの医薬品有効成分市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の医薬品有効成分市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの医薬品有効成分市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Teva、Novartis、Pfizer、Johnson & Johnson、Mylan、North China Pharmaceutical Group、Dr. Reddy’s Laboratories、Roche、Aurobindo pharma、Sun Pharmaceutical Industries、Boehringer Ingelheim GmbH、Bayer、BASF、DSM、Zhejiang Medicine、Biocon、Johnson Matthey、Hisun Pharmacy、Cambrex、Shandong Xinhua Pharmaceutical、Lonza group、Huahai Pharmaceutical、Haerbin Pharmaceutical Group、Cipla、Tian Yao、Lupin、North East Pharmaceutical、Albemarle、Shandong Lukang Pharmaceutical、Jiangsu Hengrui Medicine
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Active Pharma Ingredient Market
The global Active Pharma Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Active Pharma Ingredient Scope and Market Size
Active Pharma Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharma Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Active Pharma Ingredient market is segmented into
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients

Segment by Application, the Active Pharma Ingredient market is segmented into
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications

Regional and Country-level Analysis
The Active Pharma Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Active Pharma Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Active Pharma Ingredient Market Share Analysis
Active Pharma Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Active Pharma Ingredient business, the date to enter into the Active Pharma Ingredient market, Active Pharma Ingredient product introduction, recent developments, etc.

The major vendors covered:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine

【レポートの目次】

1 Study Coverage
1.1 Active Pharma Ingredient Product Introduction
1.2 Market Segments
1.3 Key Active Pharma Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Pharma Ingredient Market Size Growth Rate by Type
1.4.2 Innovative Active Pharmaceutical Ingredients
1.4.3 Generic Active Pharmaceutical Ingredients
1.5 Market by Application
1.5.1 Global Active Pharma Ingredient Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiovascular Disease
1.5.4 Diabetes
1.5.5 Central Nervous System and Neurological Disorders
1.5.6 Endocrinology
1.5.7 Other Therapeutic Applications
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Active Pharma Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Active Pharma Ingredient Revenue 2015-2026
2.1.2 Global Active Pharma Ingredient Sales 2015-2026
2.2 Global Active Pharma Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Active Pharma Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Active Pharma Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Active Pharma Ingredient Competitor Landscape by Players
3.1 Active Pharma Ingredient Sales by Manufacturers
3.1.1 Active Pharma Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Active Pharma Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Active Pharma Ingredient Revenue by Manufacturers
3.2.1 Active Pharma Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Active Pharma Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Pharma Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Pharma Ingredient Revenue in 2019
3.2.5 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Active Pharma Ingredient Price by Manufacturers
3.4 Active Pharma Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Active Pharma Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharma Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharma Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Active Pharma Ingredient Market Size by Type (2015-2020)
4.1.1 Global Active Pharma Ingredient Sales by Type (2015-2020)
4.1.2 Global Active Pharma Ingredient Revenue by Type (2015-2020)
4.1.3 Active Pharma Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Pharma Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Pharma Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharma Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Active Pharma Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Pharma Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Active Pharma Ingredient Market Size by Application (2015-2020)
5.1.1 Global Active Pharma Ingredient Sales by Application (2015-2020)
5.1.2 Global Active Pharma Ingredient Revenue by Application (2015-2020)
5.1.3 Active Pharma Ingredient Price by Application (2015-2020)
5.2 Active Pharma Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Pharma Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharma Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharma Ingredient Price Forecast by Application (2021-2026)

6 North America
6.1 North America Active Pharma Ingredient by Country
6.1.1 North America Active Pharma Ingredient Sales by Country
6.1.2 North America Active Pharma Ingredient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Active Pharma Ingredient Market Facts & Figures by Type
6.3 North America Active Pharma Ingredient Market Facts & Figures by Application

7 Europe
7.1 Europe Active Pharma Ingredient by Country
7.1.1 Europe Active Pharma Ingredient Sales by Country
7.1.2 Europe Active Pharma Ingredient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharma Ingredient Market Facts & Figures by Type
7.3 Europe Active Pharma Ingredient Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Active Pharma Ingredient by Region
8.1.1 Asia Pacific Active Pharma Ingredient Sales by Region
8.1.2 Asia Pacific Active Pharma Ingredient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Type
8.3 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Application

9 Latin America
9.1 Latin America Active Pharma Ingredient by Country
9.1.1 Latin America Active Pharma Ingredient Sales by Country
9.1.2 Latin America Active Pharma Ingredient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Active Pharma Ingredient Market Facts & Figures by Type
9.3 Central & South America Active Pharma Ingredient Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Active Pharma Ingredient by Country
10.1.1 Middle East and Africa Active Pharma Ingredient Sales by Country
10.1.2 Middle East and Africa Active Pharma Ingredient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Type
10.3 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Application

11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharma Ingredient Products Offered
11.1.5 Teva Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Active Pharma Ingredient Products Offered
11.2.5 Novartis Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Active Pharma Ingredient Products Offered
11.3.5 Pfizer Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Active Pharma Ingredient Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Active Pharma Ingredient Products Offered
11.5.5 Mylan Related Developments
11.6 North China Pharmaceutical Group
11.6.1 North China Pharmaceutical Group Corporation Information
11.6.2 North China Pharmaceutical Group Description and Business Overview
11.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 North China Pharmaceutical Group Active Pharma Ingredient Products Offered
11.6.5 North China Pharmaceutical Group Related Developments
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Corporation Information
11.7.2 Dr. Reddy’s Laboratories Description and Business Overview
11.7.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Products Offered
11.7.5 Dr. Reddy’s Laboratories Related Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description and Business Overview
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche Active Pharma Ingredient Products Offered
11.8.5 Roche Related Developments
11.9 Aurobindo pharma
11.9.1 Aurobindo pharma Corporation Information
11.9.2 Aurobindo pharma Description and Business Overview
11.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aurobindo pharma Active Pharma Ingredient Products Offered
11.9.5 Aurobindo pharma Related Developments
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Corporation Information
11.10.2 Sun Pharmaceutical Industries Description and Business Overview
11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Products Offered
11.10.5 Sun Pharmaceutical Industries Related Developments
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Description and Business Overview
11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharma Ingredient Products Offered
11.1.5 Teva Related Developments
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description and Business Overview
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Related Developments
11.13 BASF
11.13.1 BASF Corporation Information
11.13.2 BASF Description and Business Overview
11.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.13.4 BASF Products Offered
11.13.5 BASF Related Developments
11.14 DSM
11.14.1 DSM Corporation Information
11.14.2 DSM Description and Business Overview
11.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
11.14.4 DSM Products Offered
11.14.5 DSM Related Developments
11.15 Zhejiang Medicine
11.15.1 Zhejiang Medicine Corporation Information
11.15.2 Zhejiang Medicine Description and Business Overview
11.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Zhejiang Medicine Products Offered
11.15.5 Zhejiang Medicine Related Developments
11.16 Biocon
11.16.1 Biocon Corporation Information
11.16.2 Biocon Description and Business Overview
11.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Biocon Products Offered
11.16.5 Biocon Related Developments
11.17 Johnson Matthey
11.17.1 Johnson Matthey Corporation Information
11.17.2 Johnson Matthey Description and Business Overview
11.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Johnson Matthey Products Offered
11.17.5 Johnson Matthey Related Developments
11.18 Hisun Pharmacy
11.18.1 Hisun Pharmacy Corporation Information
11.18.2 Hisun Pharmacy Description and Business Overview
11.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Hisun Pharmacy Products Offered
11.18.5 Hisun Pharmacy Related Developments
11.19 Cambrex
11.19.1 Cambrex Corporation Information
11.19.2 Cambrex Description and Business Overview
11.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Cambrex Products Offered
11.19.5 Cambrex Related Developments
11.20 Shandong Xinhua Pharmaceutical
11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
11.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
11.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Shandong Xinhua Pharmaceutical Products Offered
11.20.5 Shandong Xinhua Pharmaceutical Related Developments
11.21 Lonza group
11.21.1 Lonza group Corporation Information
11.21.2 Lonza group Description and Business Overview
11.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Lonza group Products Offered
11.21.5 Lonza group Related Developments
11.22 Huahai Pharmaceutical
11.22.1 Huahai Pharmaceutical Corporation Information
11.22.2 Huahai Pharmaceutical Description and Business Overview
11.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Huahai Pharmaceutical Products Offered
11.22.5 Huahai Pharmaceutical Related Developments
11.23 Haerbin Pharmaceutical Group
11.23.1 Haerbin Pharmaceutical Group Corporation Information
11.23.2 Haerbin Pharmaceutical Group Description and Business Overview
11.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Haerbin Pharmaceutical Group Products Offered
11.23.5 Haerbin Pharmaceutical Group Related Developments
11.24 Cipla
11.24.1 Cipla Corporation Information
11.24.2 Cipla Description and Business Overview
11.24.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Cipla Products Offered
11.24.5 Cipla Related Developments
11.25 Tian Yao
11.25.1 Tian Yao Corporation Information
11.25.2 Tian Yao Description and Business Overview
11.25.3 Tian Yao Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Tian Yao Products Offered
11.25.5 Tian Yao Related Developments
11.26 Lupin
11.26.1 Lupin Corporation Information
11.26.2 Lupin Description and Business Overview
11.26.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.26.4 Lupin Products Offered
11.26.5 Lupin Related Developments
11.27 North East Pharmaceutical
11.27.1 North East Pharmaceutical Corporation Information
11.27.2 North East Pharmaceutical Description and Business Overview
11.27.3 North East Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.27.4 North East Pharmaceutical Products Offered
11.27.5 North East Pharmaceutical Related Developments
11.28 Albemarle
11.28.1 Albemarle Corporation Information
11.28.2 Albemarle Description and Business Overview
11.28.3 Albemarle Sales, Revenue and Gross Margin (2015-2020)
11.28.4 Albemarle Products Offered
11.28.5 Albemarle Related Developments
11.29 Shandong Lukang Pharmaceutical
11.29.1 Shandong Lukang Pharmaceutical Corporation Information
11.29.2 Shandong Lukang Pharmaceutical Description and Business Overview
11.29.3 Shandong Lukang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.29.4 Shandong Lukang Pharmaceutical Products Offered
11.29.5 Shandong Lukang Pharmaceutical Related Developments
11.30 Jiangsu Hengrui Medicine
11.30.1 Jiangsu Hengrui Medicine Corporation Information
11.30.2 Jiangsu Hengrui Medicine Description and Business Overview
11.30.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
11.30.4 Jiangsu Hengrui Medicine Products Offered
11.30.5 Jiangsu Hengrui Medicine Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Active Pharma Ingredient Market Estimates and Projections by Region
12.1.1 Global Active Pharma Ingredient Sales Forecast by Regions 2021-2026
12.1.2 Global Active Pharma Ingredient Revenue Forecast by Regions 2021-2026
12.2 North America Active Pharma Ingredient Market Size Forecast (2021-2026)
12.2.1 North America: Active Pharma Ingredient Sales Forecast (2021-2026)
12.2.2 North America: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.2.3 North America: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
12.3 Europe Active Pharma Ingredient Market Size Forecast (2021-2026)
12.3.1 Europe: Active Pharma Ingredient Sales Forecast (2021-2026)
12.3.2 Europe: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.3.3 Europe: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Active Pharma Ingredient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Active Pharma Ingredient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Active Pharma Ingredient Market Size Forecast by Region (2021-2026)
12.5 Latin America Active Pharma Ingredient Market Size Forecast (2021-2026)
12.5.1 Latin America: Active Pharma Ingredient Sales Forecast (2021-2026)
12.5.2 Latin America: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.5.3 Latin America: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Active Pharma Ingredient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Active Pharma Ingredient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Active Pharma Ingredient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Active Pharma Ingredient Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharma Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Teva、Novartis、Pfizer、Johnson & Johnson、Mylan、North China Pharmaceutical Group、Dr. Reddy’s Laboratories、Roche、Aurobindo pharma、Sun Pharmaceutical Industries、Boehringer Ingelheim GmbH、Bayer、BASF、DSM、Zhejiang Medicine、Biocon、Johnson Matthey、Hisun Pharmacy、Cambrex、Shandong Xinhua Pharmaceutical、Lonza group、Huahai Pharmaceutical、Haerbin Pharmaceutical Group、Cipla、Tian Yao、Lupin、North East Pharmaceutical、Albemarle、Shandong Lukang Pharmaceutical、Jiangsu Hengrui Medicine

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の医薬品有効成分市場2026:インサイト・予測(Global Active Pharma Ingredient Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。